Country of manufacture: Poland, IC EN Polfa Rzeszow Poland, Akrichin HFC Russia, Balkanpharma-Dupnica AD Bulgaria, Vilar Russia, Glaxo Wellcome Poznań Poland, Grindex Aktionernoe obshchesti Latvia, Magistra KiK Romania, Moscow Pharmaceutical Factory Russia, Poznań
Pharm Group: Synthetic laxatives
Producers: Polfa, Rzeszowskie Zaklady Farmaceutyczne SA (Poland), IC EN Polfa Rzeszów (Poland), Akrichin HFC (Russia), Balkanfarma-Dupnitsa AD (Bulgaria), Vilar (Russia), Glaxo Wellcome Poznań (Poland), Grindex Joint Stock Company (Latvia), Magistra KiC (Romania), Moscow Pharmaceutical Factory (Russia)
International name: Bisacodyl
Synonyms: Apo-Bisacodyl, Bisadil, Bisacodyl-Acri, Bisacodyl-Nijpharm, Bisacodyl-FPO, Bisacodyl-Hemopharm, Dulcolax, Laxacodyl, Laxatin, Laxbene, Pirilax, Stadalax international
Pharmaceutical forms: coated tablets 5mg, dragees 5mg, suppositories 10mg, substance, suppositories 0.01g, tablets coated with a coating 5mg, tablets 5mg, suppositories 10mg, rectal suppositories 10mg
Composition: Active substance - Bisacodyl.
Indications for use: Chronic constipation of various etiologies, bowel cleansing before diagnostic and surgical interventions.
Contraindications: Hypersensitivity, injured hernia, intestinal obstruction, spastic constipation, hemorrhoids, acute inflammatory diseases of abdominal organs, bleeding in the gastrointestinal tract and uterus, cystitis, breast age (up to 1 year). Restrictions on use: hepatic and/or renal failure, pregnancy.
Side effects: Dyspeptic disorders, pain in the epigastrium or in the entire abdomen, allergic reactions.
Interaction: No data.
Overdosage: Manifested by diarrhea with loss of large amounts of fluid and electrolytes (muscle weakness, convulsions). Treatment: symptomatic.
Special instructions: No data available.
References: Encyclopedia of Medicines 2004.